跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POSIFORLID 20 MG/G POMADA OFTALMICA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
POSIFORLID 20 MG/G POMADA OFTALMICA
Approved
STANDARD
POSIFORLID 20 MG/G POMADA OFTALMICA
Brill Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 16, 2022
Approval ID
e177f4c44732413a
Company
Brill Pharma S.L.
Type
Standard
Approval Details
Approval Id
e177f4c44732413a
Drug Cima Aemps Name
POSIFORLID 20 MG/G POMADA OFTALMICA
Register Number
86633
Holder Company Name
Brill Pharma S.L.
Marketing Company Name
Brill Pharma S.L.
Authorization Date
2022-03-16
Dosage Form
POMADA OFTÁLMICA
Dose
20 mg/g
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Brill Pharma S.L.
Active Ingredients
BIBROCATOL
20 mg/g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 16, 2022
Approval ID
e177f4c44732413a
Type
Standard
Back to CIMA-AEMPS Approvals